Markets:

Overview

News

Currencies

International

Treasuries

Atea Pharmaceuticals, Inc. - common stock (NQ:AVIR)

5.278 +0.298 (+5.99%)

Streaming Delayed Price Updated: 10:53 AM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atea Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 Next >

Atea Pharma's Investigational Dengue Treatment Fast Tracked In US ↗

September 26, 2022

Via Benzinga

Atea Pharmaceuticals To Advance Global Late-Stage COVID-19 Study of Bemnifosbuvir ↗

September 13, 2022

Via Benzinga

Recap: Atea Pharmaceuticals Q2 Earnings ↗

August 08, 2022

Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Is Merck Stock A Buy Amid Reports It Could Buy Seagen For $40 Billion? ↗

July 07, 2022

Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?

Via Investor's Business Daily

Stocks Selling For Less Than Cash Per Share ↗

July 03, 2022

How do you go about choosing a stock to buy in these volatile times? One strategy is to look for stocks that are not only selling below their book value, but also below their cash per share, especially...

Via Talk Markets

Short Volatility Alert: Atea Pharmaceuticals ↗

May 18, 2022

On Tuesday, shares of Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) experienced volatile short activity. After the activity, the stock price went down -1.73% to $7.38. The...

Via Benzinga

Atea Pharmaceuticals: Q1 Earnings Insights ↗

May 10, 2022

Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

Expert Ratings For Atea Pharmaceuticals ↗

January 06, 2022

Atea Pharmaceuticals (NASDAQ:AVIR) has observed the following analyst ratin...

Via Benzinga

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Preview For Atea Pharmaceuticals ↗

May 09, 2022

Atea Pharmaceuticals (NASDAQ:AVIR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Atea...

Via Benzinga

How To Attend Atea Pharmaceuticals Q1 2022 Earnings Conference Call ↗

May 05, 2022

Atea Pharmaceuticals (NASDAQ:AVIR) will host a conference call at 10:00 AM ET on May 10, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

April 25, 2022

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

NASDAQ:AVIR Investor Notice: Investigation over Potential Wrongdoing at Atea Pharmaceuticals, Inc. ↗

April 05, 2022

San Diego, CA -- (SBWIRE) -- 04/05/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Atea Pharmaceuticals, Inc.

Via SBWire

30 Stocks Moving in Tuesday's Pre-Market Session ↗

March 15, 2022

Gainers Incannex Healthcare Limited (NASDAQ: IXHL) rose 118.2% to $49.97 in pre-market trading after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary...

Via Benzinga

44 Stocks Moving In Tuesday's Mid-Day Session ↗

March 01, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3...

Via Benzinga

27 Stocks Moving in Monday's Pre-Market Session ↗

March 01, 2022

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) rose 28.6...

Via Benzinga

Atea Pharmaceuticals: Q4 Earnings Insights ↗

February 28, 2022

Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q4 earnings results on Monday, February 28, 2022 at 04:01 PM. Here's what investors need to know about the announcement....

Via Benzinga

Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes ↗

February 11, 2022

Drug behemoth Pfizer was the first to launch a Covid antiviral pill — but a pack of small biotech stocks are already nipping at its heels.

Via Investor's Business Daily

NASDAQ:AVIR Investor Notice: Investigation over Possible Securities Laws Violations by Atea Pharmaceuticals, Inc. ↗

February 02, 2022

San Diego, CA -- (SBWIRE) -- 02/02/2022 -- Atea Pharmaceuticals, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales ↗

February 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Atea Pharmaceuticals, Inc. (AVIR) Investigation

January 12, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

7 Pharmaceutical Stocks That Could Make You Rich ↗

January 06, 2022

Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022 ↗

January 06, 2022

Upgrades For Canada Goose Holdings Inc (NYSE:

Via Benzinga

The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO ↗

December 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron...

Via Benzinga

After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial ↗

December 15, 2021

Atea Pharmaceuticals Inc (NASDAQ: AVIR) said it would close the global Phase 3 MORNINGSKY trial. The decision comes after considering the changing COVID-19 landscape...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 18, 2021

Gainers NeuroOne Medical Tech (NASDAQ:NMTC...

Via Benzinga

What 5 Analyst Ratings Have To Say About Atea Pharmaceuticals ↗

November 18, 2021

Over the past 3 months, 5 analysts have published their opinion on Atea Pharmaceuticals (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021 ↗

November 18, 2021

Upgrades Macquarie upgraded the previous rating for ZTO Express (Cayman) Inc (NYSE:

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.